FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103133513> ?p ?o ?g. }

• W2103133513 endingPage "2533" @default.
• W2103133513 startingPage "2527" @default.
• W2103133513 abstract "To determine the efficacy and toxicity of the drug combination of carboplatin, paclitaxel, and gemcitabine in patients with advanced urothelial carcinoma.Patients eligible included those with advanced urothelial malignancy of any histology, no previous chemotherapy for metastatic disease, Southwest Oncology Group performance status of 2 or less, serum creatinine levels of 2 mg/dL or less, and adequate bone marrow and hepatic function. Treatment consisted of paclitaxel 200 mg/m2, carboplatin (target area under the curve = 5) on day 1, and gemcitabine 800 mg/m2 on days 1 and 8, repeated every 21 days.Forty-nine patients (44 men and five women) were enrolled; the patients' median age was 63 years, and their median creatinine clearance was 78 mL/min (range, 26 to 165 mL/min). Forty-three patients had transitional cell carcinoma, and six had squamous cell carcinoma or mixed histology. Ten patients had metastases to lymph nodes only, six had locally advanced disease, four had locally recurrent disease, 24 patients had visceral metastases, and five had soft tissue metastases. Twenty-one patients had disease in one site, 16 in two sites, and 12 in three sites. A total of 272 cycles were administered (median, six cycles; range, 1 to 15 cycles). Major toxicities were grade 3 and 4 neutropenia in 17 and 19 patients, respectively; grade 3 and 4 thrombocytopenia in 15 and six patients, respectively; grade 3 and 4 anemia in 10 and two patients, respectively; grade 3 neuropathy in four patients; and diarrhea in two patients. The incidence of febrile neutropenia was 1.4%; no patients died of drug toxicity. Forty-seven of the 49 patients were assessable for response. Fifteen (32%) patients experienced a complete response, and 17 (36%) patients experienced a partial response (32 of 47 patients, 68%; 95% confidence interval, 56.27 to 82.86). Responses were seen in all sites, including 15 (68%) of 22 patients with visceral metastases. The median survival was 14.7 months, with a 1-year survival of 59%.Combination paclitaxel, carboplatin, and gemcitabine is active; an encouraging number of patients with advanced urothelial carcinoma treated with this regimen experienced complete remission." @default.
• W2103133513 created "2016-06-24" @default.
• W2103133513 creator A5004935250 @default.
• W2103133513 creator A5021595416 @default.
• W2103133513 creator A5041126882 @default.
• W2103133513 creator A5050058361 @default.
• W2103133513 creator A5073593424 @default.
• W2103133513 date "2001-05-01" @default.
• W2103133513 modified "2023-10-10" @default.
• W2103133513 title "Combination Paclitaxel, Carboplatin, and Gemcitabine Is an Active Treatment for Advanced Urothelial Cancer" @default.
• W2103133513 cites W1786169419 @default.
• W2103133513 cites W1820014750 @default.
• W2103133513 cites W1840050571 @default.
• W2103133513 cites W1855374361 @default.
• W2103133513 cites W1857682357 @default.
• W2103133513 cites W1862964936 @default.
• W2103133513 cites W1867318780 @default.
• W2103133513 cites W1893740135 @default.
• W2103133513 cites W1936664258 @default.
• W2103133513 cites W1939723756 @default.
• W2103133513 cites W1941332786 @default.
• W2103133513 cites W1945195571 @default.
• W2103133513 cites W1957837469 @default.
• W2103133513 cites W1975316159 @default.
• W2103133513 cites W1975976475 @default.
• W2103133513 cites W1990786881 @default.
• W2103133513 cites W1995597101 @default.
• W2103133513 cites W2008281779 @default.
• W2103133513 cites W2047108938 @default.
• W2103133513 cites W2101562875 @default.
• W2103133513 cites W2116996913 @default.
• W2103133513 cites W2165427711 @default.
• W2103133513 cites W2240844634 @default.
• W2103133513 doi "https://doi.org/10.1200/jco.2001.19.9.2527" @default.
• W2103133513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11331332" @default.
• W2103133513 hasPublicationYear "2001" @default.
• W2103133513 type Work @default.
• W2103133513 sameAs 2103133513 @default.
• W2103133513 citedByCount "190" @default.
• W2103133513 countsByYear W21031335132012 @default.
• W2103133513 countsByYear W21031335132013 @default.
• W2103133513 countsByYear W21031335132014 @default.
• W2103133513 countsByYear W21031335132015 @default.
• W2103133513 countsByYear W21031335132016 @default.
• W2103133513 countsByYear W21031335132017 @default.
• W2103133513 countsByYear W21031335132018 @default.
• W2103133513 countsByYear W21031335132019 @default.
• W2103133513 countsByYear W21031335132020 @default.
• W2103133513 countsByYear W21031335132021 @default.
• W2103133513 countsByYear W21031335132022 @default.
• W2103133513 countsByYear W21031335132023 @default.
• W2103133513 crossrefType "journal-article" @default.
• W2103133513 hasAuthorship W2103133513A5004935250 @default.
• W2103133513 hasAuthorship W2103133513A5021595416 @default.
• W2103133513 hasAuthorship W2103133513A5041126882 @default.
• W2103133513 hasAuthorship W2103133513A5050058361 @default.
• W2103133513 hasAuthorship W2103133513A5073593424 @default.
• W2103133513 hasConcept C126322002 @default.
• W2103133513 hasConcept C126894567 @default.
• W2103133513 hasConcept C141071460 @default.
• W2103133513 hasConcept C2776694085 @default.
• W2103133513 hasConcept C2776907518 @default.
• W2103133513 hasConcept C2777063308 @default.
• W2103133513 hasConcept C2778239845 @default.
• W2103133513 hasConcept C2778248108 @default.
• W2103133513 hasConcept C2780258809 @default.
• W2103133513 hasConcept C2781451048 @default.
• W2103133513 hasConcept C71924100 @default.
• W2103133513 hasConcept C90924648 @default.
• W2103133513 hasConceptScore W2103133513C126322002 @default.
• W2103133513 hasConceptScore W2103133513C126894567 @default.
• W2103133513 hasConceptScore W2103133513C141071460 @default.
• W2103133513 hasConceptScore W2103133513C2776694085 @default.
• W2103133513 hasConceptScore W2103133513C2776907518 @default.
• W2103133513 hasConceptScore W2103133513C2777063308 @default.
• W2103133513 hasConceptScore W2103133513C2778239845 @default.
• W2103133513 hasConceptScore W2103133513C2778248108 @default.
• W2103133513 hasConceptScore W2103133513C2780258809 @default.
• W2103133513 hasConceptScore W2103133513C2781451048 @default.
• W2103133513 hasConceptScore W2103133513C71924100 @default.
• W2103133513 hasConceptScore W2103133513C90924648 @default.
• W2103133513 hasIssue "9" @default.
• W2103133513 hasLocation W21031335131 @default.
• W2103133513 hasLocation W21031335132 @default.
• W2103133513 hasOpenAccess W2103133513 @default.
• W2103133513 hasPrimaryLocation W21031335131 @default.
• W2103133513 hasRelatedWork W192472069 @default.
• W2103133513 hasRelatedWork W2081749499 @default.
• W2103133513 hasRelatedWork W2092515994 @default.
• W2103133513 hasRelatedWork W2138113364 @default.
• W2103133513 hasRelatedWork W2164332056 @default.
• W2103133513 hasRelatedWork W2375370454 @default.
• W2103133513 hasRelatedWork W2395412721 @default.
• W2103133513 hasRelatedWork W2412822991 @default.
• W2103133513 hasRelatedWork W2419621113 @default.
• W2103133513 hasRelatedWork W2095749210 @default.
• W2103133513 hasVolume "19" @default.
• W2103133513 isParatext "false" @default.

• next